Table 2.

Median values of serum iron biomarkers in subjects by incident HCC status The UPMC NAFLD Cohort Study, 2004 – 2018

Serum iron biomarkers	Incident HCC		Free of HCC
	N	Median (5%, 95%)	N	Median (5%, 95%)	P*
Iron (μg/dl)	188	70.5 (19.0, 171.0)	15,586	69.0 (19.0, 141.0)	0.897
Transferrin Saturation ( %)	175	19.4 (5.0, 49.0)	13,697	20.0 (5.4, 44.0)	0.704
TIBC (μg/dl)	224	335.5 (174.0, 503.0)	16,304	348.0 (191.0, 485.0)	0.180
Ferritin (μg /dl)	219	8.3 (0.8, 98.1)	16,111	10.0 (0.9, 70.0)	0.445

HCC: hepatocellular carcinoma; NAFLD: non-alcoholic fatty liver disease; TIBC: total iron binding capacity.

^*Derived from the Wilcoxon rank sum test.